High Induction of IL-6 Secretion From hUCMSCs Optimize the Potential of hUCMSCs and TCZ as Therapy for COVID-19-Related ARDS

Biological and cellular interleukin-6 (IL-6)-related therapies have been used to treat severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure, which prompted further exploration of the role of IL-6 in human umbilical cord mesenchymal stem cell (hUCMSC) therapy. Perip...

Descripción completa

Detalles Bibliográficos
Autores principales: Lo, Huei-Yu, Cheng, Shun-Ping, Huang, Jing-Long, Chang, Kuo-Ting, Chang, Yu-Lung, Huang, Chien-Hsun, Chang, Chia-Jen, Chiu, Chien-Hua, Chen-Yang, Yui Whei, Chan, Chin-Kan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Special Collection on Cell Transplantation and COVID-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586187/
https://www.ncbi.nlm.nih.gov/pubmed/34757857
http://dx.doi.org/10.1177/09636897211054481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586187/
https://www.ncbi.nlm.nih.gov/pubmed/34757857
http://dx.doi.org/10.1177/09636897211054481

Ejemplares similares